דוקסורוביצין אבווה 2 מגמל
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DOXORUBICIN HYDROCHLORIDE
Available from:
NOVARTIS ISRAEL LTD
ATC code:
L01DB01
Pharmaceutical form:
SOLUTION FOR INFUSION
Composition:
DOXORUBICIN HYDROCHLORIDE 2 MG/ML
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
EBEWE PHARMA GES.M.B.H NFG.KG, AUSTRIA
Therapeutic group:
DOXORUBICIN
Therapeutic area:
DOXORUBICIN
Therapeutic indications:
Soft tissue and bone sarcomas, Hodgkin's and non-Hodgkin's lymphoma, acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilms` tumor, carcinomas of the thyroid, breast, ovary, bladder, small cell bronchogenic carcinoma and neuroblastoma.
Authorization date:
2014-04-30
